Opaleye Management Inc.
Q4 2013 13F-HR Holdings
Net value change ($000)
—
New positions
22
Sold out positions
0
Turnover %
100.0%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to previous filing: —
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| GENTIUM SPA SPONSORED ADR | 29,240 | — |
| GERN | 13,200 | — |
| PHARMACYCLICS INC | 12,960 | — |
| ARIAD PHARMACEUTICALS INC | 11,857 | — |
| NPS PHARMACEUTICALS INC | 5,945 | — |
| OMER | 5,060 | — |
| LAB | 5,035 | — |
| LGND | 4,860 | — |
| CEMPRA INC | 4,745 | — |
| Cardiovascular Systems Inc | 4,455 | — |
Top Reduces (Value $000, Stocks/ETFs)
| — |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|